Free for all members. Non-members can purchase this event for $89 AUD.
Welcome to the webinar ‘The ANZJP GRADE Guidelines for the Management of Schizophrenia 2026’.
Join Professor Dan Siskind and Professor Shuichi Suetani for a clinically grounded overview of the ANZJP GRADE guidelines for the management of schizophrenia (2026). This webinar focuses on how to apply evidence-based recommendations within an individualised, collaborative formulation and how the GRADE framework clarifies certainty of evidence and strength of recommendations for real-world decision-making.
In this session, Professors Siskind and Suetani will:
- Walk through the guideline architecture and what “strong vs conditional” recommendations mean in practice.
- Review first-episode psychosis assessment: organic differentials, baseline investigations, and longitudinal physical health monitoring.
- Discuss antipsychotic selection: balancing efficacy, tolerability, side-effect burden, and patient priorities across illness stages.
- Summarise evidence for psychological and psychosocial interventions, including options when medication is declined.
- Cover key domains across the course of illness: comorbidity, substance use, lifestyle and physical health, and family/whānau/carer involvement, including considerations for special populations.
Register to strengthen your understanding of graded recommendations and their practical application in contemporary schizophrenia care.
Access Information:
- The event is open to all attendees.
- Non-members may purchase access for $89 AUD, which includes live attendance and one month of on-demand viewing following release.
- Academy members receive live access and on-demand access for the full duration of their active subscription.
- A recording will be available for on-demand access following the live event.
Upon completion of this event, participants will receive 1.5 CPD hours towards educational activities.
Speaker profile – Professor Shuichi Suetani
Professor Shuichi Suetani is a community psychiatrist in Queensland. Alongside his psychiatry training, Shuichi completed a PhD exploring the epidemiological relationships between physical activity and mental disorders. Shuichi has numerous publications in high-impact journals, including The Lancet Psychiatry and JAMA Psychiatry. He is Associate Editor for Therapeutic Advances in Psychopharmacology and the Australian and New Zealand Journal of Psychiatry, and also sits on the Editorial Board of the British Journal of Psychiatry.
Speaker profile – Professor Dan Siskind
Professor Siskind trained as a psychiatrist in Australia and the United States. He works clinically as a psychiatrist in Brisbane, Australia, with people with treatment-refractory schizophrenia. His research interests include treatment-refractory schizophrenia, clozapine and the physical health comorbidities associated with schizophrenia. He has over 300 publications and AU$60 million in competitive research grants, with over AU$7 million as Chief Investigator.
Host – Dr Sanil Rege
Dr Sanil Rege is a consultant psychiatrist and academic, with dual qualifications from the UK and Australia. He is a Fellow of the Royal Australian and New Zealand College of Psychiatrists and a Member of the Royal College of Psychiatrists (UK).
The Academy Membership provides access to a range of courses and webinars throughout the year as part of the annual subscription. This webinar is also available for individual purchase for those who are not currently members.
For non-members. Access to this course only.
This includes access to the webinar, plus
all future webinars and 150+ on-demand courses
Already an Academy member? Log in to your Academy account and register for the course through your dashboard.